Three University of Arizona fraternities are under investigation after allegations of extreme hazing, drug use and ...

Industry Leaders lists, an expansion of the TIME100 Most Influential Companies issue that dives deeper into 20 sectors to ...

Alpha Cognition, Inc. ("Alpha Cognition", "ACI", or the "Company"), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, today announced that Michael ...

The laborious process of naming a pharmaceutical takes months and sometimes years of brainstorming, trademark review, legal ...

Trump's executive order accelerates ibogaine research, offering veterans new hope for PTSD and brain injury treatment.

Critical Path Institute’s® Critical Path for Alpha-1 Antitrypsin Deficiency Consortium today announced the addition of AIRNA as its newest industry partner, bringing RNA editing expertise to the ...

Google's once-forgotten Cloud division is making a run on the strength of Gemini.

Arkansans have been familiar with Lyme disease and "tick fever" since the 1970s, but Alpha-gal syndrome has only been formally identified since the early 2000s. More than 110,000 suspected cases were ...

The process of discovering a new drug has historically been agonisingly slow and tremendously expensive. In recent years, artificial intelligence has promised to drastically accelerate this timeline ...

Across the neon-lit streets of Bangkok and the quiet rice paddies of Isaan, a quiet storm is brewing in Thailand.

Dogwood licensed SP16 to treat cancer-related pain from partner and regulatory sponsor Serpin Pharma The SP16 Phase 1b trial fully funded by the National Cancer Institute; Patient enrollment expected ...